5 June 2019
Congratulations to Kennedy researchers Professor Chris Buckley, Professor Mark Coles and Dr Stephen Sansom who have been awarded £1.5M funding from the Medical Research Council (MRC) to explore fibroblasts as an emerging target to treat chronic inflammatory disease.
30 May 2019
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
28 May 2019
New research at the Kennedy Institute reveals potential of a novel class of drugs for the treatment of rheumatoid arthritis.
7 May 2019
Dr Fiona Watt has been awarded a prestigious UK Research and Innovation (UKRI) Future Leaders Fellowship to further her research for better treatments for people living with, or at risk of the commonest form of arthritis, osteoarthritis.
18 April 2019
Two articles from the Kennedy Institute review the latest in understanding immune control in the gut and skin and explain how this knowledge is being translated into new treatments for inflammatory disease
29 March 2019
Oxford researchers gathered at the Kennedy Institute earlier this month to learn how advanced imaging technologies, such as super resolution microscopy, are pushing the boundaries of scientific discovery.
27 March 2019
A recent workshop at Pembroke College, Oxford, provided a showcase for research within the Arthritis Therapy Acceleration Programme (A-TAP) aimed at speeding up the delivery of new drugs for immune-mediated inflammatory disease (IMIDs).
18 February 2019
The Oxford Centre for Microbiome Studies (OCMS) provides unique access to essential technologies to speed up our understanding of how the microbes that inhabit our bodies influence health and disease.
New drug class could offer a targeted safer treatment alternative for patients with rheumatoid arthritis
15 February 2019
A new treatment targeting tenascin-C could reduce the progression and severity of rheumatoid arthritis (RA) at the very early stages of disease.
12 February 2019
Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells – may play an important role in survival after surgery to remove pancreatic cancer.
25 January 2019
Macrophages treated with the short-chain fatty acid butyrate – a by-product of dietary fibre breakdown - are better equipped to fight bacteria in the gut, report researchers from the Kennedy Institute and the Translational Gastroenterology Unit. These findings could lead to new strategies to restore gut health in inflammatory bowel disease (IBD).
23 January 2019
Oxford scientists are set to benefit from one of the biggest funding grants ever awarded by Cancer Research UK.
21 January 2019
Kennedy researchers, in collaboration with colleagues at the Botnar Research Centre, Oxford, and the Universities of Birmingham and Leeds, have been awarded strategic funding from the Medical Research Council (MRC) to map in detail the different types of cells that make up human joints.
21 December 2018
A recycling and sustainability event at the Kennedy Institute created a forum for staff to explore new ways to promote sustainability in the workplace.
7 December 2018
The report highlights recent scientific achievements, and sets out the Institute’s strategy to bridge the gap between discovery research and clinical application.
30 November 2018
Dr Luke Jostins-Dean from the Kennedy Institute and Professor Deborah Gill from the Radcliffe Department of Medicine at the University of Oxford will be swapping a lab coat for legislation at the House of Commons for a week in Westminster.
14 November 2018
Kennedy Institute Professor Michael Dustin and Professor Omer Dushek of the Dunn School of Pathology have published an explanatory article in the prestigious Nature Immunology, leading thought on ground-breaking work in the field of immune regulation.
13 November 2018
The Kennedy Institute is part of a flagship Human Cell Atlas project recently awarded £7m from the Wellcome Trust.